According to the report, the global vascular grafts market size is projected to garner $ 8.5 billion by 2030, registering a CAGR of 5.24% from 2022 to 2030. The report contains 150+ pages with detailed analysis.
The vascular graft market shows a tremendous growth owing to the increase in the number of minimally invasive procedures carried out by the technically advanced hospitals and healthcare systems. This minimally invasive procedure has become a major part of many surgical procedures related to the vital organs in the human body.
Market Overview
A recent report provides crucial insights along with application based and forecast information in the global vascular grafts market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the vascular grafts market.
Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1758
The main objective of this research report is to define and describe the market and offer a complete valuation of the market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents a breakdown of the market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2022 to 2030.
This research report evaluates the vascular grafts market on a global and regional level. It offers a thorough analysis of the market status, growth, and forecast of the global vascular grafts market for the period from 2017 to 2030. This research study offers historic data for the years 2017 to 2020 along with a forecast from 2022 to 2030 based on value.
Report Scope of the Vascular Grafts Market
| Report Coverage | Details |
| Market Size by 2030 | USD 8.5 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.24% |
| North America Market Share in 2021 | 31% |
| Endovascular Stent Grafts Market Share in 2021 | 64% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End User, Raw Material, Geography |
Report Highlights
- On the basis of the product, the endovascular stent grafts segment is expected to dominate the market in the forecast period. The developments in the endovascular applications will lead to a growth in the endovascular stent grafts market.
- The cardiac aneurysm segment will grow during the forecast period as the congenital heart disease and other congenital heart surgeries which are carried out using the advanced tissue engineered grafts is in demand and the demand shall grow.
- On the basis of the raw material used, the polytetrafluoroethylene segment is expected to grow during the forecast period, it is used for the peripheral bypass procedures as this material adequately interacts with the tissue and it is extremely easy to use.
Regional Snapshots
The region of North America is considered to be the largest ground for the development of this market. Owing to the rising health care awareness, availability of facilities, high number of people living in this developed country, high availability of reimbursement and the shift to advanced procedures are helping the market to grow. However, the region of Asia Pacific has also shown a tremendous growth during the forecast. This region is seen to have a high number of patients suffering with cardiovascular diseases, kidney problems and diabetes which helped to fuel this market to a great extent. The other regions which help in the growth of this market are Europe and Russia which also have a great number of cases with cardiovascular diseases and renal disorders.
Market Dynamics
Drivers
The factors driving this market includes the high number of chronic kidney diseases amongst the people, the increase in the number of dialysis that take place, the high rate of diabetic individuals. Moreover, the existence of cardiovascular diseases and renal disorders has helped to grow the market to a great extent. The adoption of minimally invasive procedures carried out by the advanced healthcare system has also increased the demand for vascular graft market over the period of time. This also helps in better healing of wounds and further reduces the complications that the patient has to undergo. The reduction in neointimal formation followed after complex vascular surgeries have shown a tremendous growth in the market during the forecast.
Restraints
The outbreak of the pandemic led to a decline in the market growth of the vascular grafts due to the interruption in the operation procedures and supply chains. As a result of the pandemic only essential services were carried out and non essential surgeries and procedures were neglected. Elective procedures had become the fashion of the ongoing market. During the pandemic the vascular and cardiac operative procedures witnessed a 8.5% decrease worldwide. Moreover, the increase in the total cost of the vascular graft procedures also hinders the growth of the market during the forecast. The developed nations opt for these services whereas the developing and underdeveloped nations face a challenge to cope with the increasing cost.
Opportunities
The increase in the minimally invasive procedures which are required for chronic heart diseases and renal diseases has provided a great opportunity for the growth of the vascular graft market. The reduced side effects and complications faced by the patients has helped the market to grow. The peripheral vascular market is another segment which shows tremendous growth due to the increased number of renal disorder and arterial diseases. All these factors provide a great opportunity to the vascular graft market during the forecast.
Challenges
The failure of a vascular graft can have severe adverse effects on the health of consumers. Malfunction of vascular grafts can cause a risk to the life of the consumer and hence the adoption of the new advanced technology will be hampered to a great extent which can affect the growth of the market in the forecast period. The higher cost associated with these kind of graphs also creates a great challenge for the developing market. Failure of a vascular graft also leads to an additional expense in which an operation has to be done again. All these factors proved to be a great challenge for the growth of the vascular graft market.
Get Our Latest Press Releases@ https://www.precedenceresearch.com/press-releases
Recent Developments
- Medtronic has obtained approval for ll/lls, Thoracic stent which is used along with Heli-FX EndoAnchor.
- In 2017, Endologix Inc has made an agreement with Deerfield management which is a healthcare organization. A funding worth $170 million has been granted to it.
Top Key Players includes in the vascular grafts market:
- Getinge AB
- Medtronic PLC
- LeMaitre vascular Inc
- WL gore and associates
- terumo corporation
- Shanghai suokang medical implants Co limited
- Cook medical
Segments covered in the report
By Product
- Vascular Grafts for Aorta Disease
- Peripheral Vascular Grafts
- Endovascular Stent Grafts
- Coronary Artery By-Pass Grafts
By Application
- Cardiac Aneurysm
- Kidney Failure
- Vascular Occlusion
- Coronary Artery Disease
By Raw Material
- Polyester Vascular Grafts
- Polytetrafluoroethylene Vascular Grafts
- Polyurethane Vascular Grafts
- Biological Material Based Vascular Grafts
- Human Saphenous and Umbilical Veins
- Tissue Engineered Materials
By End User
- Hospitals
- Ambulatory Surgical Centers
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Why should you invest in this report?
If you are aiming to enter the global vascular grafts market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for vascular grafts are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Vascular Grafts Market
5.1. COVID-19 Landscape: Vascular Grafts Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Vascular Grafts Market, By Product
8.1. Vascular Grafts Market, by Product Type, 2022-2030
8.1.1. Vascular Grafts for Aorta Disease
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Peripheral Vascular Grafts
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Endovascular Stent Grafts
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Coronary Artery By-Pass Grafts
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Vascular Grafts Market, By End Use
9.1. Vascular Grafts Market, by End Use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Vascular Grafts Market, By Application Type
10.1. Vascular Grafts Market, by Application Type, 2022-2030
10.1.1. Cardiac Aneurysm
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Kidney Failure
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Vascular Occlusion
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Coronary Artery Disease
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Vascular Grafts Market, By Raw Material Type
11.1. Vascular Grafts Market, by Raw Material Type, 2022-2030
11.1.1. Polyester Vascular Grafts
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Polytetrafluoroethylene Vascular Grafts
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Polyurethane Vascular Grafts
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Biological Material Based Vascular Grafts
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Human Saphenous and Umbilical Veins
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Tissue Engineered Materials
11.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Vascular Grafts Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by End Use (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by End Use (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Raw Material Type (2017-2030)
Chapter 13. Company Profiles
13.1. Getinge AB
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic PLC
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. LeMaitre vascular Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. WL gore and associates
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. terumo corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Shanghai suokang medical implants Co limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cook Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1758
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: [email protected]
